At times in recent years, it seemed like digital technologies would never live up to the hype in healthcare. In many cases, they still haven’t. But some have turned a corner and are starting to have a real impact.
Devices with health-minded features, such as home-monitoring systems and smart watches, are helping patients and doctors monitor daily health. The first prescription mobile apps have been cleared by the FDA and are rolling out. Machine learning and other artificial intelligence tools are enhancing treatment plans, improving drug discovery, and augmenting clinicians’ skills in tasks such as reading medical scans and diagnosing disease.
It’s all exciting, but the technologies are also raising questions about data privacy and ownership, clinical integration, business models, and the future of healthcare jobs.
Xconomy plans to explore these questions and more at our second annual X·CON conference, being held Oct. 22 outside Boston. (Click here to purchase a ticket before prices go up.)
Digital Health Gets Real will convene an elite group of business and technology executives in healthcare, life sciences, pharma, software, devices, and other innovation fields. The full-day program will give attendees a chance to tap into cutting-edge advances at the intersection of tech and health; build relationships with other high-level executives; explore bold ideas for solving healthcare’s biggest challenges; and share lessons learned in integrating tech in health and life sciences.
The conference will take place in a special setting: the deCordova Sculpture Park and Museum in Lincoln, MA. Located just outside of Boston, the venue will give attendees a break from the hubbub of the city and hopefully spark everyone’s curiosity and creativity.
We’re still adding speakers, but we’ve already assembled a stellar lineup that includes:
—John Halamka, a physician, digital health thought leader, Harvard professor, and head of innovation at Beth Israel Lahey Health
—Jessica Zeaske, a partner at Echo Health Ventures and former director of healthcare investments at GE Ventures
—Kenneth Harper, vice president and general manager of healthcare virtual assistants at speech technology giant Nuance Communications
—Corey McCann, CEO of Pear Therapeutics, the first company to receive FDA clearance for a prescription mobile app intended to help treat a disease
—Spring Behrouz, CEO of NeuroInitiative, which is using computer simulation software and other technologies to try to discover drug candidates for neurodegenerative diseases
—Eric Gastfriend, CEO of DynamiCare Health, which uses a mobile app and gamified financial incentives to help recovering addicts stay clean
You won’t want to miss this event, so grab a ticket and we’ll see you in October!
